ArticleWorld journal of urology2017

Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.

Claus G Roehrborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.